AU2001236817A1 - Insulin homolog polypeptide zins4 - Google Patents

Insulin homolog polypeptide zins4

Info

Publication number
AU2001236817A1
AU2001236817A1 AU2001236817A AU3681701A AU2001236817A1 AU 2001236817 A1 AU2001236817 A1 AU 2001236817A1 AU 2001236817 A AU2001236817 A AU 2001236817A AU 3681701 A AU3681701 A AU 3681701A AU 2001236817 A1 AU2001236817 A1 AU 2001236817A1
Authority
AU
Australia
Prior art keywords
zins4
homolog polypeptide
insulin homolog
insulin
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001236817A
Inventor
James L. Holloway
Stephen R. Jaspers
Si Lok
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zymogenetics Inc
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Publication of AU2001236817A1 publication Critical patent/AU2001236817A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6454Dibasic site splicing serine proteases, e.g. kexin (3.4.21.61); furin (3.4.21.75) and other proprotein convertases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/64Relaxins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Reproductive Health (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Wood Science & Technology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • General Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2001236817A 2000-03-10 2001-02-09 Insulin homolog polypeptide zins4 Abandoned AU2001236817A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US52334600A 2000-03-10 2000-03-10
US09523346 2000-03-10
PCT/US2001/004199 WO2001068862A1 (en) 2000-03-10 2001-02-09 Insulin homolog polypeptide zins4

Publications (1)

Publication Number Publication Date
AU2001236817A1 true AU2001236817A1 (en) 2001-09-24

Family

ID=24084640

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001236817A Abandoned AU2001236817A1 (en) 2000-03-10 2001-02-09 Insulin homolog polypeptide zins4

Country Status (5)

Country Link
EP (1) EP1294887A1 (en)
JP (1) JP2003526373A (en)
AU (1) AU2001236817A1 (en)
CA (1) CA2402614A1 (en)
WO (1) WO2001068862A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1283260A4 (en) 2000-04-21 2004-08-18 Takeda Chemical Industries Ltd Novel insulin/igf/relaxin family polypeptides and dnas thereof
AUPR814401A0 (en) * 2001-10-08 2001-11-01 Howard Florey Institute Of Experimental Physiology And Medicine Human 3 relaxin
US20050026194A1 (en) * 2003-06-20 2005-02-03 Tularik Inc. Gene amplification and overexpression in cancer
WO2005075641A1 (en) 2004-02-09 2005-08-18 Eisai R & D Management Co., Ltd. Screening method
US7893197B2 (en) 2004-08-25 2011-02-22 Janssen Pharmaceutica N.V. Relaxin-3 chimeric polypeptides and their preparation and use
WO2006026355A2 (en) * 2004-08-25 2006-03-09 Janssen Pharmaceutica N.V. Relaxin-chimeric polypeptides and their preparation and use
WO2008094437A2 (en) 2007-01-30 2008-08-07 Janssen Pharmaceutica N.V. Chimeric peptide antagonist for gpcr135 or gpcr142

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998005782A1 (en) * 1996-08-02 1998-02-12 Zymogenetics, Inc. Testis-specific insulin homolog polypeptides
EP0932669A1 (en) * 1996-10-15 1999-08-04 ZymoGenetics Insulin homologs
WO1998027210A1 (en) * 1996-12-16 1998-06-25 Zymogenetics, Inc. Compositions and methods for stimulating pancreatic islet cell regeneration

Also Published As

Publication number Publication date
CA2402614A1 (en) 2001-09-20
JP2003526373A (en) 2003-09-09
EP1294887A1 (en) 2003-03-26
WO2001068862A1 (en) 2001-09-20

Similar Documents

Publication Publication Date Title
AU2001289309A1 (en) Improved safety syringe
AU2631001A (en) Novel fgf homolog zfgf11
AU2919001A (en) Syringe
AU2001274548A1 (en) Syringe
AU2001278755A1 (en) Injections
AU2759201A (en) Novel fgf homolog zfgf12
AU2001259837A1 (en) Therapeutic pore-forming peptides
AU2001284418A1 (en) Novel polypeptide
AU2001236817A1 (en) Insulin homolog polypeptide zins4
AU5706000A (en) Useful polypeptide
AU1541601A (en) Syringes
GB0015761D0 (en) Polypeptide
AU2001260236A1 (en) Restricted use syringe
AU2691500A (en) Novel polypeptide
HK1053062A1 (en) Pernasally absorbable insulin preparations
AU4778600A (en) Novel polypeptide
AU2109200A (en) Polypeptide
AU2001278975A1 (en) Alpha-conotoxin peptides
GB0121215D0 (en) Polypeptide
AU6637700A (en) Tryptase-like polypeptide ztryp1
AU2002224056A1 (en) Novel polypeptide
AU2001234855A1 (en) Neuropeptide-like polypeptide zpep17
AU4351900A (en) Inducible vaccines
GB0008877D0 (en) Polypeptide delivery system
AU2463401A (en) Novel fgf homolog zfgf10